CNNOverweight people lost 35 to 52 pounds on newly approved diabetes drug, study saysJun 7, 2022Virginia Langmaid & Sandee LaMotteBy Virginia Langmaid & Sandee LaMottemore_vert
Investors | Eli Lilly and CompanyLilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between ...May 13, 2022more_vert
MedscapeTirzepatide Powers 'Unprecedented' Weight Loss in Obesity TrialJun 4, 2022Mitchel L. ZolerBy Mitchel L. Zolermore_vert
Everyday HealthType 2 Diabetes Drug Tirzepatide (Mounjaro) Aids Weight Loss in People With Obesity: StudyJun 6, 2022Lisa RapaportBy Lisa Rapaportmore_vert
The GuardianDiabetes drug leads to notable weight loss in people with obesity – studyJun 5, 2022Nicola DavisBy Nicola Davismore_vert
USA TODAYDiabetes drug could be a game changer for obesity, new study showsJun 4, 2022Karen WeintraubBy Karen Weintraubmore_vert